Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis

By  

Current Pharmaceutical Design, Vol. 22, Iss. 2, 2016-01 ,pp. : 180-188

Bentham Science Publishers

Access to resources Recommend Favorite

Complementary Therapies in Inflammatory Bowel Diseases

By  

Current Drug Targets, Vol. 15, Iss. 11, 2014-10 ,pp. : 1079-1088

Bentham Science Publishers

Access to resources Recommend Favorite

Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn’s disease

By Fiedler T.   Büning C.   Reuter W.   Pitre G.   Gentz E.   Schmidt HH.   Büttner J.   Ockenga J.   Gerloff T.   Meisel C.   Lochs H.   Roots I.   Köpke K.   Johne A.  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 10, 2007-10 ,pp. : 917-925

Springer Publishing Company

Access to resources Recommend Favorite

Probiotics and Immune Regulation of Inflammatory Bowel Diseases

By  

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 145-154

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammatory bowel diseases: a new wave of therapy

By Murthy S.   Flanigan A.   Osborne B.J.   Murthy N.S.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 785-818

Informa Healthcare

Access to resources Recommend Favorite